Natixis Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Natixis Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,976	Closed	-$684K	–	1868
2026 Q1	$684K	Buy	+12,976	New	+$533K	﹤0.01%	1464

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Natixis Advisors's TERN Position: Q2 2026 in Review

Natixis Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 12,976 shares — an estimated $684K sold.

Natixis Advisors first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $684K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Natixis Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Natixis Advisors sold 12,976 Terns Pharmaceuticals shares in Q2 2026, an estimated $684K.
Natixis Advisors first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Natixis Advisors's Terns Pharmaceuticals position peaked at $684K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.